Armata Pharmaceuticals Inc (ARMP) is a Healthcare · Biotechnology company listed on NYSE MKT. Price $4.33 (+5.61%), Market cap $0.30B, 52-week low–high $1.84 ~ $14.80.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Financial statements, price targets, institutional (13F) holdings and related news for Armata Pharmaceuticals Inc are updated in real time on BlackAll Trade.
Armata Pharmaceuticals Inc trades at $4.33 (+5.61%). Real-time quotes and charts are available on BlackAll Trade.
Armata Pharmaceuticals Inc has a market cap of about $0.30B.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It